COLORADO GENERAL ASSEMBLY - STATUTORY REPORTS


Prescription Drug Monitoring Program Task Force Report
Statutory Cite:Next Due Date:Frequency:Report Status:Repeal Date:
12-280-409 (2)Jul 1, 2022AnnualOngoing
HB 19-1172
HB 14-1283
12-280-409. Examination and analysis of prescription drug monitoring program - recommendations to executive director. (2) If the executive director convenes a task force or obtains assistance from the Colorado team, the applicable group shall submit annual reports to the executive director and the general assembly detailing its findings and recommendations. Notwithstanding section 24-1-136 (11), the requirement in this section to report to the general assembly continues indefinitely.
(1) The executive director shall create a prescription drugmonitoring program task force or consult with and request assistance from the Colorado team assembled by the governor's office to develop a strategic plan to reduce prescription drug misuse, or its successor group, in order to:
(a) Examine issues, opportunities, and weaknesses of the program, including how personal information is secured in the program and whether inclusion of personal identifying information in the program and access to that information is necessary; and
(b) Make recommendations to the executive director on ways to make the program a more effective tool for practitioners and pharmacists in order to reduce prescription drug misuse in this state.

12-280-409 (2)       Previously 12-42.5-408.5 (2)
Pursuant to Section 24-1-136 (9), C.R.S., Colorado state departments and agencies submit all statutorily required reports to Colorado Legislative Council staff. The Colorado Legislative Council staff delivers these reports to the appropriate legislative recipients and makes them available on this site. The Colorado Legislative Council is the non partisan research staff for the Colorado General Assembly.  If you have any questions, please contact the Colorado Legislative Council: lcs.ga@state.co.us; 303-866-3521.